Gain of Function

Original price was: $3.44.Current price is: $1.99.

Clothing Size Conversion Chart
Category US EU UK Chest (in) Waist (in) Hips (in)
Men XS 44 34 32-34 26-28 33-35
S 46 36 34-36 28-30 35-37
M 48 38 38-40 32-34 39-41
L 50 40 42-44 36-38 43-45
XL 52 42 46-48 40-42 47-49
Women XS 32 6 31-32 24-25 33-34
S 34 8 33-34 26-27 35-36
M 36 10 35-36 28-29 37-38
L 38-40 12-14 37-39 30-32 39-41
XL 42 16 40-42 33-35 42-44
Youth XS 128 7 26-28 23-24 26-28
S 134 8 28-30 24-25 28-30
M 140 10 30-32 25-26 30-32
L 146 12 32-34 26-27 32-34
XL 152 14 34-36 27-28 34-36
Pants Size Conversion Chart
CategoryUSEUUKWaist (in)Hip (in)Inseam (in)
Men284428283430
304630303631
324832323832
345034344033
365236364234
Women0324243430
2346253530
4368263631
63810273832
84012284032
Shoes Size Conversion Chart
CategoryUSEUUKFoot Length (in)
Men6395.59.25
7406.59.625
8417.510
9428.510.25
10439.510.625
114410.511
124511.511.25
134612.511.625
Women5352.58.5
6363.58.875
7374.59.25
8385.59.625
9396.510
10407.510.25
11418.510.625
12429.511
M (Unisex)5374.58.75
6385.59
7396.59.5
8407.510
9418.510.25
10429.510.625
114310.511
124411.511.25
69 People watching this product now!
Description

How a small number of risky experiments creates many unwieldy problems for life science research.

The life sciences have never been more critical to human health, wealth, and security. But with any endeavor comes risk, and the last decade has seen concerns raised about gain-of function-research in which a microbe, usually a virus, is given new properties like enhanced lethality, transmissibility, or the capability to infect new species. In 2021 the term seeped into the tabloids when a conflict between Senator Rand Paul and Dr. Anthony Fauci arose over the origins of COVID-19. In Gain of Function, Nicholas Evans-who has spent his career studying gain-of-function research-describes what this kind of research is, what it isn’t, and why a small number of scientific experiments continues to make headlines.

Evans begins with a description of what gain-of-function research is in science, and what it means in government policy. He tells the story of the original papers that sparked controversy more than a decade ago, unpacking them for readers unfamiliar with virology research, and he identifies where and why policymakers and scientists alike became concerned. He then turns to the history of policies that attempt to regulate gain-of-function research, the current controversies, and the ethics of risky research. He concludes with the future of gain of function, including how debates about gain of function will influence science and public health in years to come.